Worapol Ngamcherdtrakul
Worapol Ngamcherdtrakul
PDX Pharmaceuticals
Dirección de correo verificada de
Citado por
Citado por
Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles
J Morry, W Ngamcherdtrakul, W Yantasee
Redox biology 11, 240-253, 2017
Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer
W Ngamcherdtrakul, J Morry, S Gu, DJ Castro, SM Goodyear, ...
Advanced functional materials 25 (18), 2646-2659, 2015
Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis
J Morry, W Ngamcherdtrakul, S Gu, SM Goodyear, DJ Castro, MM Reda, ...
Biomaterials 66, 41-52, 2015
Novel oral detoxification of mercury, cadmium, and lead with thiol-modified nanoporous silica
T Sangvanich, J Morry, C Fox, W Ngamcherdtrakul, S Goodyear, D Castro, ...
ACS applied materials & interfaces 6 (8), 5483-5493, 2014
Targeted treatment of metastatic breast cancer by PLK1 siRNA delivered by an antioxidant nanoparticle platform
J Morry, W Ngamcherdtrakul, S Gu, M Reda, DJ Castro, T Sangvanich, ...
Molecular cancer therapeutics 16 (4), 763-772, 2017
Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery
W Ngamcherdtrakul, T Sangvanich, M Reda, S Gu, D Bejan, W Yantasee
International journal of nanomedicine 13, 4015, 2018
Therapeutic siRNA for drug-resistant HER2-positive breast cancer
S Gu, Z Hu, W Ngamcherdtrakul, DJ Castro, J Morry, MM Reda, JW Gray, ...
Oncotarget 7 (12), 14727, 2016
PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer
M Reda, W Ngamcherdtrakul, S Gu, DS Bejan, N Siriwon, JW Gray, ...
Cancer letters 467, 9-18, 2019
Current development of targeted oligonucleotide-based cancer therapies: perspective on HER2-positive breast cancer treatment
W Ngamcherdtrakul, DJ Castro, S Gu, J Morry, M Reda, JW Gray, ...
Cancer treatment reviews 45, 19-29, 2016
siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion
W Ngamcherdtrakul, W Yantasee
Translational Research 214, 105-120, 2019
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
MA Nelson, W Ngamcherdtrakul, SW Luoh, W Yantasee
Cancer and Metastasis Reviews 40 (2), 519-536, 2021
Selective capture of radionuclides (U, Pu, Th, Am and Co) using functional nanoporous sorbents
W Yantasee, GE Fryxell, K Pattamakomsan, T Sangvanich, RJ Wiacek, ...
Journal of hazardous materials 366, 677-683, 2019
Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment
S Gu, W Ngamcherdtrakul, M Reda, Z Hu, JW Gray, W Yantasee
PloS one 13 (6), e0198141, 2018
In situ tumor vaccination with nanoparticle co‐delivering CpG and STAT3 siRNA to effectively induce whole‐body antitumor immune response
W Ngamcherdtrakul, M Reda, MA Nelson, R Wang, HY Zaidan, DS Bejan, ...
Advanced Materials 33 (31), 2100628, 2021
Cross-linked polymer modified nanoparticles
W Yantasee, W Ngamcherdtrakul, J Morry, D Castro, J Gray
US Patent 11,207,428, 2021
Lanthanide-loaded nanoparticles as potential fluorescent and mass probes for high-content protein analysis
W Ngamcherdtrakul, T Sangvanich, S Goodyear, M Reda, S Gu, ...
Bioengineering 6 (1), 23, 2019
Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model
W Ngamcherdtrakul, J Morry, T Sangvanich, M Reda, DS Bejan, ...
Scientific Reports 9 (1), 1-9, 2019
Nanoporous sorbent material as an oral phosphate binder and for aqueous phosphate, chromate, and arsenate removal
T Sangvanich, W Ngamcherdtrakul, R Lee, J Morry, D Castro, GE Fryxell, ...
Journal of nanomedicine & nanotechnology 5, 2014
Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery
R Salve, P Kumar, W Ngamcherdtrakul, V Gajbhiye, W Yantasee
Materials Science and Engineering: C 124, 112084, 2021
Cancer Nanomedicine: Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer (Adv. Funct. Mater. 18 …
W Ngamcherdtrakul, J Morry, S Gu, DJ Castro, SM Goodyear, ...
Advanced Functional Materials 25 (18), 2629-2629, 2015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20